324 related articles for article (PubMed ID: 18560421)
1. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
2. Lentivirus Mediated Correction of Artemis-Deficient Severe Combined Immunodeficiency.
Punwani D; Kawahara M; Yu J; Sanford U; Roy S; Patel K; Carbonaro DA; Karlen AD; Khan S; Cornetta K; Rothe M; Schambach A; Kohn DB; Malech HL; McIvor RS; Puck JM; Cowan MJ
Hum Gene Ther; 2017 Jan; 28(1):112-124. PubMed ID: 27611239
[TBL] [Abstract][Full Text] [Related]
3. Role of transgene regulation in ex vivo lentiviral correction of artemis deficiency.
Multhaup MM; Podetz-Pedersen KM; Karlen AD; Olson ER; Gunther R; Somia NV; Blazar BR; Cowan MJ; McIvor RS
Hum Gene Ther; 2015 Apr; 26(4):232-43. PubMed ID: 25738323
[TBL] [Abstract][Full Text] [Related]
4. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.
Mostoslavsky G; Fabian AJ; Rooney S; Alt FW; Mulligan RC
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16406-11. PubMed ID: 17062750
[TBL] [Abstract][Full Text] [Related]
5. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
[TBL] [Abstract][Full Text] [Related]
6. In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.
Adjali O; Marodon G; Steinberg M; Mongellaz C; Thomas-Vaslin V; Jacquet C; Taylor N; Klatzmann D
J Clin Invest; 2005 Aug; 115(8):2287-95. PubMed ID: 16075064
[TBL] [Abstract][Full Text] [Related]
7. Lentiviral Gene Therapy for Artemis-Deficient SCID.
Cowan MJ; Yu J; Facchino J; Fraser-Browne C; Sanford U; Kawahara M; Dara J; Long-Boyle J; Oh J; Chan W; Chag S; Broderick L; Chellapandian D; Decaluwe H; Golski C; Hu D; Kuo CY; Miller HK; Petrovic A; Currier R; Hilton JF; Punwani D; Dvorak CC; Malech HL; McIvor RS; Puck JM
N Engl J Med; 2022 Dec; 387(25):2344-2355. PubMed ID: 36546626
[TBL] [Abstract][Full Text] [Related]
8. T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.
Xiao TZ; Singh K; Dunn E; Ramachandran R; Cowan MJ
Biol Blood Marrow Transplant; 2012 Feb; 18(2):200-9. PubMed ID: 22015994
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the human artemis promoter by heterologous gene expression in vitro and in vivo.
Multhaup MM; Gurram S; Podetz-Pedersen KM; Karlen AD; Swanson DL; Somia NV; Hackett PB; Cowan MJ; McIvor RS
DNA Cell Biol; 2011 Oct; 30(10):751-61. PubMed ID: 21663454
[TBL] [Abstract][Full Text] [Related]
10. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of the Artemis murine counterpart results in SCID and defective V(D)J recombination that is partially corrected with bone marrow transplantation.
Li L; Salido E; Zhou Y; Bhattacharyya S; Yannone SM; Dunn E; Meneses J; Feeney AJ; Cowan MJ
J Immunol; 2005 Feb; 174(4):2420-8. PubMed ID: 15699179
[TBL] [Abstract][Full Text] [Related]
12. Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells.
Rivière J; Hauer J; Poirot L; Brochet J; Souque P; Mollier K; Gouble A; Charneau P; Fischer A; Pâques F; de Villartay JP; Cavazzana M
Gene Ther; 2014 May; 21(5):529-32. PubMed ID: 24622732
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice.
Chen W; Wu X; Levasseur DN; Liu H; Lai L; Kappes JC; Townes TM
Stem Cells; 2000; 18(5):352-9. PubMed ID: 11007919
[TBL] [Abstract][Full Text] [Related]
14. Pretransplant mobilization with granulocyte colony-stimulating factor improves B-cell reconstitution by lentiviral vector gene therapy in SCID-X1 mice.
Huston MW; Riegman AR; Yadak R; van Helsdingen Y; de Boer H; van Til NP; Wagemaker G
Hum Gene Ther; 2014 Oct; 25(10):905-14. PubMed ID: 25222508
[TBL] [Abstract][Full Text] [Related]
15. Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.
Tuckett AZ; Thornton RH; O'Reilly RJ; van den Brink MRM; Zakrzewski JL
J Hematol Oncol; 2017 May; 10(1):109. PubMed ID: 28511686
[TBL] [Abstract][Full Text] [Related]
16. Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene.
van Til NP; de Boer H; Mashamba N; Wabik A; Huston M; Visser TP; Fontana E; Poliani PL; Cassani B; Zhang F; Thrasher AJ; Villa A; Wagemaker G
Mol Ther; 2012 Oct; 20(10):1968-80. PubMed ID: 22692499
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells.
Barclay SL; Yang Y; Zhang S; Fong R; Barraza A; Nolta JA; Torbett BE; Abedi M; Bauer G; Anderson JS
Stem Cells; 2015 Mar; 33(3):870-9. PubMed ID: 25524029
[TBL] [Abstract][Full Text] [Related]
18. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency.
Yates F; Malassis-Séris M; Stockholm D; Bouneaud C; Larousserie F; Noguiez-Hellin P; Danos O; Kohn DB; Fischer A; de Villartay JP; Cavazzana-Calvo M
Blood; 2002 Dec; 100(12):3942-9. PubMed ID: 12393742
[TBL] [Abstract][Full Text] [Related]
20. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
Smogorzewska EM; Weinberg KI; Kohn DB
Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
